High incidence of atrial fibrillation in patients treated with ibrutinib

Bibliographic Details
Title: High incidence of atrial fibrillation in patients treated with ibrutinib
Authors: Florian Baptiste, Jennifer Cautela, Yan Ancedy, Noémie Resseguier, Thérèse Aurran, Laure Farnault, Marion Escudier, Chloé Ammar, Mélanie Gaubert, Charles Dolladille, Jeremie Barraud, Michael Peyrol, Ariel Cohen, Franck Paganelli, Joachim Alexandre, Stephane Ederhy, Franck Thuny
Source: Open Heart, Vol 6, Iss 1 (2019)
Publisher Information: BMJ Publishing Group, 2019.
Publication Year: 2019
Collection: LCC:Diseases of the circulatory (Cardiovascular) system
Subject Terms: Diseases of the circulatory (Cardiovascular) system, RC666-701
More Details: Objective Atrial fibrillation (AF) is one of the most common side effects of ibrutinib, a drug that has dramatically improved the prognosis of chronic B-cell malignancies such as chronic lymphocytic leukaemia (CLL). The true incidence of ibrutinib-related AF (IRAF) is not well known and its therapeutic management poses unique challenges especially due to the inherent risk of bleeding. We aimed to determine the incidence and predictors of IRAF, and to analyse its management and outcome.Methods A standardised monitoring was applied at two cardio-oncology clinics in consecutive patients referred before and during ibrutinib therapy. The primary endpoint was the incidence of IRAF. The excess of AF incidence with ibrutinib was studied by comparing the incidence of IRAF with the expected incidence of AF in general population and in patients with CLL not exposed to ibrutinib.Results 53 patients were included. The incidence of IRAF was 38% at 2 years and the risk was 15-fold higher than the AF risk in both the general population and patients with CLL not exposed to ibrutinib (p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2053-3624
Relation: https://openheart.bmj.com/content/6/1/e001049.full; https://doaj.org/toc/2053-3624
DOI: 10.1136/openhrt-2019-001049
Access URL: https://doaj.org/article/e141364c960c483e884ff8da784b3ca4
Accession Number: edsdoj.141364c960c483e884ff8da784b3ca4
Database: Directory of Open Access Journals
More Details
ISSN:20533624
DOI:10.1136/openhrt-2019-001049
Published in:Open Heart
Language:English